Psoriatic Arthritis Resource Center

Psoriatic Arthritis

Ixekizumab for Psoriatic Arthritis: Follow-Up Safety Data from SPIRIT

Ixekizumab demonstrated favorable tolerability and safety, in line with previous reports, for treatment of psoriatic arthritis, according to a large safety analysis of the...
Psoriatic Arthritis Worsens QoL in Patients With PsoriasisPsoriatic Arthritis Worsens QoL in Patients With Psoriasis

Psoriatic Arthritis Worsens QoL in Patients With Psoriasis

People with psoriasis/psoriatic arthritis (PsA) have a decreased ability to participate in social roles and activities and more depressive symptoms than those with psoriasis...
Cognitive Decline Ups Bone Fracture Risk, and More

Rheumatology Round-up: Six-Year Outcomes of ACL Revision Surgery; and More

RA Predictors ID'd in Undifferentiated Large Joint Arthritis Autoantibody positivity and subclinical synovitis are independent predictors of rheumatoid arthritis (RA) among patients presenting with undifferentiated...
oral, surgeon, treatments, Rheum Round-up: Skyrizi Receives Conditional Approval, Tea and Fracture, PKR vs. TKR, and More

Rheum Round-up: Oral Microbiome Different in RA, Biologics Comparison, and more

A recent study observed differences in oral microbiome between patients with early rheumatoid arthritis (RA) or at high-risk of the disease compared to controls....
Golimumab, ustekinumab

Ustekinumab Versus Other Biologics in Psoriatic Disease: Which Medications Increase Risk for Infection?

In a recent study, researchers compared ustekinumab versus other biologics and apremilast for risk of serious infection requiring hospitalization among patients with psoriasis (PsO)...
Psoriatic Arthritis Worsens QoL in Patients With PsoriasisPsoriatic Arthritis Worsens QoL in Patients With Psoriasis

Patient Characteristics at Diagnosis May Predict 10-Year Psoriasis Disease Course

Early identification of certain patient factors may predict long-term outcomes in psoriasis, according to a study. Between 2001 and 2005, patients were enrolled in the...
Golimumab, ustekinumab

Golimumab Treatment Retention Comparison: RA, AxSpA, and PsA

A study retrospectively compared rates of treatment retention with golimumab among patients with rheumatoid arthritis (RA), axial spondyloarthritis (AxSpA), and psoriatic arthritis (PsA). “Retention of...

Curated Journal Reading List